Therapeutic peptides are preferentially solubilized in specific microenvironments within PEG-PLGA polymer nanoparticles

Christian Lorenz,Raquel Lopez-Rios De Castro,Robert Ziolek,Martin Ulmschneider

DOI: https://doi.org/10.26434/chemrxiv-2023-q80dn

2023-11-15

Abstract:Polymeric nanoparticles represent a highly promising drug delivery formulation. However, a lack of understanding of the molecular mechanisms that underlie their drug solubilization and controlled release capabilities has hindered efficient clinical translation of such technologies. Polyethylene glycol-poly(lactic-co-glycolic) acid (PEG-PLGA) nanoparticles have been widely studied as cancer drug delivery vehicles. In this manuscript we use unbiased coarse-grained molecular dynamics simulations to model the self-assembly of a PEG-PLGA nanoparticle and its solubulization of the anticancer peptide, EEK. This nanoformulation has been shown to be efficacious against triple negative breast cancer cells \textit{in vivo}. The physical characteristics of our simulated PEG-PLGA nanoparticles are in good agreement with the previously reported experimentalquantities. To describe the internal structure of the nanoparticles, we apply unsupervised machine learning techniques to quantify the conformations that polymers adopt at various locations within the nanoparticle. We find that the local microenvironments formed by the various polymer conformations promote preferential EEK solubilization within specific regions of the NP. This demonstrates that these microenvironments are key in controlling drug storage locations within nanoparticles, implying that the individual polymer conformations within such nanoparticles are potentially tunable parameters for the rational design of new polymer nanoparticles for therapeutic applications.

Chemistry

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the insufficient understanding of the molecular mechanisms in drug delivery of polyethylene glycol - poly(lactic - co - glycolic acid) (PEG - PLGA) nanoparticles. Specifically, although PEG - PLGA nanoparticles have been widely studied as carriers for anticancer drugs and have shown good effects in in - vitro experiments and animal models, the understanding of their internal structures, drug solvation capabilities, and the specific molecular mechanisms of their interactions with cells remains limited. This lack of understanding hinders the efficient translation of these technologies in clinical applications.

To overcome this challenge, the authors used unbiased coarse - grained molecular dynamics simulations to model the self - assembly process of PEG - PLGA nanoparticles and their solvation capabilities for the anticancer peptide EEK. Through this method, the study aims to reveal at the molecular level how PEG - PLGA nanoparticles promote drug storage by forming specific local microenvironments, especially the preferential solvation of EEK in specific regions of the nanoparticles. The study also explored the control effect of these local microenvironments on the drug storage location, suggesting that the adjustability of polymer conformations within the nanoparticles may be a key parameter for the rational design of new polymer nanoparticles for therapeutic applications.

The core objective of the paper is to provide a molecular - level understanding, through molecular dynamics simulations combined with unsupervised machine - learning techniques, that the drug - loading capacity of PEG - PLGA nanoparticles depends not only on the overall structure but also on the specific conformations adopted by individual polymers within the nanoparticles. These different local chemical environments regulate drug encapsulation, thus providing new insights into the location - specific solvation of drugs in nanoparticles.